Litcius/Paper detail

Anti-vascular endothelial growth factor treatment potentiates immune checkpoint blockade through a BAFF- and IL-12-dependent reprogramming of the TME

Mohamed-Reda Benmebarek, Cihan Oguz, Matthias Seifert, Benjamin Ruf, Yuta Myojin, Kylynda C. Bauer, Patrick Huang, Chi Ma, Marina Villamor-Payà, Francisco Rodríguez-Matos, Marlaine Soliman, Rajiv Trehan, Cecilia Monge, Changqing Xie, David E. Kleiner, Bradford J. Wood, Elliot Levy, Anuradha Budhu, Noémi Kedei, Christian T. Mayer, Xin Wei Wang, Justin Lack, William G. Telford, Firouzeh Korangy, Tim F. Greten

2025Immunity31 citationsDOIOpen Access PDF

Topics & Concepts

BlockadeReprogrammingBiologyImmune checkpointImmunologyCancer researchB-cell activating factorImmune systemImmunotherapyReceptorAntibodyCellGeneticsBiochemistryB cellImmune cells in cancerCancer Immunotherapy and BiomarkersAngiogenesis and VEGF in Cancer